Remove 2018 Remove Hospital Remove Nuclear Medicine
article thumbnail

Society of Nuclear Medicine and Molecular Imaging Names Helen Nadel, MD, FRCPC, of Stanford, as President, Announces New Officers at SNMMI 2023 Annual Meeting

Imaging Technology

Urbain, MD, PhD, FASNC , professor of radiology/nuclear medicine and medicine, vice chair of theranostics, and director of nuclear medicine at Roswell Park Cancer Center at the University of Buffalo , Buffalo, New York. and ‘How can we ensure diversity in all parts of the nuclear medicine family?’

article thumbnail

Meet the Minnies 2024 finalists

AuntMinnie

Louis School of Medicine and completed his residency and a neuroradiology fellowship at Massachusetts General Hospital in Boston. In 2018 he received an endowed professorship from the university. Dempsey began working in radiography at Mercy Fitzgerald Hospital in Darby, Pennsylvania. Dmitry Beyder.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

article thumbnail

FAPI-PET shows promise for detecting pancreatic cancer

AuntMinnie

FAPI-PET imaging may become a powerful diagnostic tool for detecting pancreatic cancer, according to a study published November 16 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine. Fibroblast activation protein (FAP) is overexpressed by fibroblast cells in various cancers.

article thumbnail

FAPI-PET shows value in staging lung cancer patients

AuntMinnie

In a review of studies that included 409 patients, the technique was superior to standard-of-care FDG-PET/CT and could potentially serve as an alternative to invasive tissue sampling procedures, nuclear medicine researchers suggested.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

article thumbnail

GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

Imaging Technology

Flavio Forrer , MD, PhD, Chairman of Nuclear Medicine in the Division of Radiology and Nuclear Medicine at Kantonsspital St. Measurement follows NEMA NU 2-2018. [v] Since there is no “typical” hospital and many variables exist, i.e. hospital size, case mix, etc. Gallen in Switzerland [vii].